Karyopharm Therapeutics Inc. buy Royal Bank of Canada
Start price
04.11.25
/
50%
€0.54
Target price
04.11.26
€16.51
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 04.11.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Karyopharm Therapeutics Inc. | - | - |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Karyopharm Therapeutics (NASDAQ:KPTI) had its price target lowered by analysts at Royal Bank Of Canada from $30.00 to $19.00. They now have an "outperform" rating on the stock.
Ratings data for KPTI provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
13.05.25
13.05.25
€29.71
13.05.26
13.05.26
-
25.02.25
25.02.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.59
20.02.25
20.02.25
€2.86
20.02.26
20.02.26
-6.32%
25.02.25
25.02.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.61
10.02.25
10.02.25
€2.91
10.02.26
10.02.26
-9.57%
25.02.25
25.02.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.72
07.08.24
07.08.24
€2.75
07.08.25
07.08.25
-25.10%
08.08.25
08.08.25
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.84
03.11.23
03.11.23
€2.80
03.11.24
03.11.24
-1.41%
04.11.24
04.11.24
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.67
03.08.23
03.08.23
€3.65
03.08.24
03.08.24
-54.66%
04.08.24
04.08.24